FilingSEC EDGAR8-K
CervoMed Announces Publication of Neflamapimod Research
· SEC accepted
StageClinical Results Published
Filing content
CervoMed announced the publication of two peer-reviewed research articles supporting neflamapimod as a potential treatment for dementia with Lewy bodies.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…